Cupric Chloride Dihydrate
| 證據等級: L5 | 預測適應症: 0 個 |
目錄
Cupric Chloride Dihydrate: No Repurposing Prediction Available
One-Sentence Summary
Cupric Chloride Dihydrate is a copper(II) salt compound used as a pharmaceutical-grade trace element source in parenteral and nutritional preparations. The TxGNN model did not generate any repurposing predictions for this compound in the current analysis run, and no original registered indications were identified in South Africa. With 0 clinical trials and 0 publications linked to a predicted indication, this candidate cannot be substantively evaluated at this time.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | Not available |
| Predicted New Indication | None identified |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 — No supporting studies identified |
| South Africa Market Status | Not Registered |
| Number of SAHPRA Registrations | 0 |
| Recommended Decision | Hold |
Clinical Trial Evidence
Currently no related clinical trials registered.
Literature Evidence
Currently no related literature available.
Safety Considerations
Please refer to the SAHPRA-approved Professional Information (PI) for safety information. Report adverse drug reactions to SAHPRA.
Conclusion and Next Steps
Decision: Hold
Rationale: The TxGNN model did not produce any repurposing predictions for Cupric Chloride Dihydrate, and no SAHPRA-registered products, original indications, safety warnings, or supporting evidence were found — making a meaningful evaluation impossible at this stage.
To proceed, the following is needed:
- Confirm the DrugBank ID for Cupric Chloride Dihydrate and retrieve full mechanism of action (MOA) data via the DrugBank API
- Download and parse the SAHPRA-approved Professional Information (PI) to obtain registered warnings and contraindications
- Verify whether any SAHPRA-registered products contain Cupric Chloride Dihydrate as an active or excipient ingredient (e.g., in trace element solutions for parenteral nutrition)
- Investigate whether this compound is registered under an alternative INN or synonym (e.g., Copper Chloride, Cupric Chloride, Copper(II) Chloride Dihydrate) that may resolve the zero-match result
- Re-run the TxGNN prediction pipeline once drug identity and DrugBank mapping are confirmed
- Conduct a targeted literature search to determine whether any therapeutic or repurposing applications have been investigated
⚠️ Research use only. This assessment is based solely on computational model outputs and does not constitute medical advice. Any repurposing candidate requires prospective clinical validation before use.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.